Cargando…
Comparative study of CA242 and CA19-9 in chronic pancreatitis.
CA242 has been proved to be useful in the diagnosis of pancreatic cancer. The aim of the present study was to clarify the mechanisms contributing to the high specificity of CA242 as compared with CA19-9 resulting from scarce serum elevation of this antigen in patients with chronic pancreatitis by co...
Autores principales: | Furuya, N., Kawa, S., Hasebe, O., Tokoo, M., Mukawa, K., Maejima, S., Oguchi, H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074436/ https://www.ncbi.nlm.nih.gov/pubmed/8562344 |
Ejemplares similares
-
Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer.
por: Kawa, S., et al.
Publicado: (1994) -
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
por: Haglund, C., et al.
Publicado: (1994) -
Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer
por: Dong, Dong, et al.
Publicado: (2018) -
Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
por: Haglund, C., et al.
Publicado: (1989) -
Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9.
por: Nilsson, O., et al.
Publicado: (1992)